The smart MDI system integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within a mobile app to deliver real-time, personalized insights and actionable guidance. The platform targets people living with diabetes who manage their condition using MDI, simplifying insulin management without adding complexity to daily life.
MiniMed won FDA clearance for the integrated offering in January.
While MiniMed offers automated insulin delivery systems like the 780G and Flex pumps, its other insulin delivery offering, InPen works within this system to deliver missed dose alerts to help minimize glucose highs and offers a dose calculator to simplify dose decision-making.
Get the full story at our sister site, Drug Delivery Business News.
